Trials / Conditions / B-Non Hodgkin Lymphoma
B-Non Hodgkin Lymphoma
6 registered clinical trials studyying B-Non Hodgkin Lymphoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia NCT06940960 | Affiliated Hospital of Guangdong Medical University | N/A |
| Not Yet Recruiting | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma NCT06879470 | He Huang | N/A |
| Recruiting | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia NCT06890065 | Shenzhen Genocury Biotech Co., Ltd. | N/A |
| Recruiting | CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or R NCT05442515 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD NCT03448393 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing NCT02315612 | National Cancer Institute (NCI) | Phase 1 |